MedTrace Logo

Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity

NCT01068418 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2017-03-30

Study results available
· View outcomes & findings →

Summary

Hypothesis: Vitamin D supplementation lower renin-angiotensin system activity in obesity.

Specific Aim: To investigate whether Vitamin D supplementation in obesity improves the vascular sensitivity to angiotensin II.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D (cholecalciferol)

cholecalciferol 15,000 IU daily for 30 days

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Jonathan S Williams, MD, MMSc · Brigham and Women's Hospital

  • Anand Vaidya, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01068418 on ClinicalTrials.gov